Options
Coumarin-Rasagiline Hybrids as Potent and Selective hMAO-B Inhibitors, Antioxidants, and Neuroprotective Agents
Fecha de emisión
2020
Autor(es)
Matos M.J.
Herrera Ibatá D.M.
Uriarte E.
Viña D.
DOI
10.1002/cmdc.202000018
Temas
Antioxidants
Coumarin-rasagiline h...
hMAO-B inhibitors
Neuroprotectors
Parkinson's disease
4 (but 2 yn 1 ylamino...
amine oxidase (flavin...
antioxidant
coumarin
monoamine oxidase inh...
neuroprotective agent...
rasagiline
unclassified drug
animal experiment
antioxidant activity
Article
DPPH radical scavengi...
embryo
enzyme inhibition
neuroprotection
nonhuman
priority journal
rat
Archivo(s)